Pregnancy Can Turn Deadly Before Prenatal Care Begins
LDI Fellow and OB-GYN Calls for Faster Testing and Better Early-Pregnancy Care
Blog Post
Chart of the Day: What’s All This Brouhaha? Today’s Private Equity Purchases of Physician Practices Look Much Like the Past
Penn LDI Study Provides Historical Analysis and Insight for the Future
Print:
The growth of private equity investment in health care is facing sharp scrutiny from investors, regulators, and the public. Some view private equity as a key to transforming the U.S. health system. Others raise concerns that profits for corporate investors will be at the expense of patients’ health, workers’ safety, and affordability. LDI Senior Fellows Mark V. Pauly and Lawton Robert Burns argue that we have seen this movie before. Looking at past private equity purchases will help us understand the future.
In their study, published in the Journal of Health Politics, Policy, and Law, they identify two historical waves of private equity investment in physician practices—in the 1990s and from the passage of the Affordable Care Act in 2010 to the present. They then assess the similarities between the investment goals of each wave—shown in the table above. Pauly and Burns say that strategies across private equity investment have largely stayed consistent. However, the investigators say there’s “less public information on firm performance” today. So, they argue, the current “brouhaha” should be tempered by past experience.
The study, “Equity Investment in Physician Practices: What’s All This Brouhaha?,” was published on February 7, 2024 in the Journal of Health Politics, Policy, and Law. Authors include Mark V. Pauly and Lawton Robert Burns.
Author
Miles Meline, MBE
Policy Coordinator
More on Health Care Access & Coverage
Can Venture Capital Help Solve America’s Maternal Health Crisis?
U.S. Startups Offer New Solutions but Raise Concerns About Medicaid Access and Equity
“High-Deductible Health Plans Are Not the Answer”
They Cut Health Spending at First but Don’t Slow Long-Term Growth Rate, LDI Fellows Say
Understanding CMS’s Proposed Rule Regarding Prior Authorization For Drugs
LDI Expert Considers Cost, Quality, and Access Implications
Congress is Fighting the Wrong Pharmacy Battle
Better Plan Choices Would Lower Drug Costs, Not PBM Breakups, LDI’s Mark Pauly Says
Why Some Family Health Insurance Is Now Much Pricier
LDI Expert Proposes Fixes to Keep Marketplace Plans Within Families’ Budgets